How An HIV Drug Is Now Helping People With Genetic Diseases

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Fierce Biotech

Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Time

New Class of HIV Drugs Spark Much-Needed Hope

There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...
NBC Los Angeles

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
KTVU

New HIV prevention drug introduced, but it comes at a high cost

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
Medscape

Changes in HIV Drug Resistance in the HAART Era

Effect of the Initial Regimen on the Rate of Specific Mutations Even among different HAART regimens, the selection of the initial regimen also has important implications in terms of selecting for ...